
    
      Children with chronic pain are randomized to one of four arms (three study drug arms, one
      placebo arm) in a randomized, double-blinded fashion. Children are treated for 2 weeks and
      then monitored for an additional 12 weeks. Study participation is a total of 14 weeks.
    
  